Stoke Therapeutics, Inc. (STOK)
29.67
-0.62
(-2.06%)
USD |
NASDAQ |
May 21, 16:00
29.78
+0.11
(+0.37%)
After-Hours: 19:59
Stoke Therapeutics Research and Development Expense (TTM) : 143.19M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biogen, Inc. | 1.607B |
| Krystal Biotech, Inc. | 54.64M |
| Scholar Rock Holding Corp. | 209.98M |
| Vertex Pharmaceuticals, Inc. | 3.891B |
| Zymeworks, Inc. | 135.72M |